Editorial Board
Chih-Sheng Chu
Kaohsiung Medical University · Taiwan, Province of China
Editorial leadership for International Journal of Lipids ISSN 2835-513X
Research interests
- Atherogenic Lipoprotein; Coronary Artery Disease; Critical Care Medicine
Biography
- Dr. Chih-Sheng (Gary) Chu M.D. PhD is now the director of core laboratory of Center of Lipid Biosciences in Kaohsiung Medical University, Kaohsiung Taiwan since 2012.
- In 2003, he received observation fellowship training in CCU of University of Virginia, VA, USA for critical care.
- In 2007, Dr. Chu became assistant professor of Internal Medicine, Kaohsiung Medical University and joined Lipid & Vascular Lab of Baylor College of Medicine, Houston, TX, USA for electronegative LDL research.
Selected publications
- Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases 2020 cited 26×
- Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis 2020 cited 20×
- Very Low-Density Lipoproteins of Metabolic Syndrome Modulates STIM1, Suppresses Store-Operated Calcium Entry, and Deranges Myofilament Proteins in Atrial Myocytes 2019 cited 16×
- VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial Fibrillation 2016 cited 16×
- An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer’s Disease 2020 cited 12×
- P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis 2023 cited 10×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJL for your work?
This journal is guided by Chih-Sheng Chu (Kaohsiung Medical University) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.